Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Annarosaria De Chiara(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 51
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
Basic principles of biobanking: from biological samples to precision medicine for patients
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021|223
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
|International Journal of Molecular Sciences|2017|112
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study
|Breast Cancer Research and Treatment|2020|70